These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1891216)

  • 21. FDA regulatory requirements for investigational new drugs and new drug applications: an update.
    Hoiberg CP; Rapaka RS
    NIDA Res Monogr; 1991; 112():313-25. PubMed ID: 1754003
    [No Abstract]   [Full Text] [Related]  

  • 22. False hope with the Right to Try Act.
    The Lancet
    Lancet; 2018 Jun; 391(10137):2296. PubMed ID: 29900858
    [No Abstract]   [Full Text] [Related]  

  • 23. Medications development and the war on drugs: victims of the Gulf war?
    Kosten TR
    Biol Psychiatry; 1991 Mar; 29(6):521-3. PubMed ID: 2054428
    [No Abstract]   [Full Text] [Related]  

  • 24. Regulatory concerns at various phases of drug development.
    Aurecchia S; Orloff D; Sobel S
    Am J Cardiol; 1998 Apr; 81(8A):2F-4F. PubMed ID: 9604895
    [No Abstract]   [Full Text] [Related]  

  • 25. The Food and Drug Administration perspective: use of an investigational drug in a medical emergency.
    Schultheis LW; Rappaport BA
    Anesth Analg; 2007 Mar; 104(3):479-80. PubMed ID: 17312189
    [No Abstract]   [Full Text] [Related]  

  • 26. Access before approval--a right to take experimental drugs?
    Okie S
    N Engl J Med; 2006 Aug; 355(5):437-40. PubMed ID: 16885545
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA regulations provide broader access to unapproved drugs.
    Shulman SR; Raiford DS
    J Clin Pharmacol; 1990 Jul; 30(7):585-7. PubMed ID: 2391391
    [No Abstract]   [Full Text] [Related]  

  • 28. Investigational drug access taken to task in lawsuit against FDA.
    Randal J
    J Natl Cancer Inst; 2003 Dec; 95(24):1818-20. PubMed ID: 14679146
    [No Abstract]   [Full Text] [Related]  

  • 29. The Food and Drug Administration's early access and fast-track approval initiatives: how have they worked?
    Shulman SR; Brown JS
    Food Drug Law J; 1995; 50(4):503-31. PubMed ID: 10343017
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug approval. Investigational access stumbles.
    Jenks S
    Med World News; 1988 Mar; 29(6):48-9. PubMed ID: 10302307
    [No Abstract]   [Full Text] [Related]  

  • 31. Expanded clinical trials of treatments for multiple sclerosis: copolymer 1 (COP-1) treatment investigational new drug (IND) program.
    Stark Y
    Ann Neurol; 1994 Jul; 36(1):114-5. PubMed ID: 8024251
    [No Abstract]   [Full Text] [Related]  

  • 32. Promoting Patient Interests in Implementing the Federal Right to Try Act.
    Lynch HF; Zettler PJ; Sarpatwari A
    JAMA; 2018 Sep; 320(9):869-870. PubMed ID: 30105394
    [No Abstract]   [Full Text] [Related]  

  • 33. Can single-patient investigational new drug studies hurry slow trains to the fast track?
    Chenoweth D
    Drug Discov Today; 2006 Mar; 11(5-6):185-6. PubMed ID: 16580594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pediatric drug development in anesthesiology: an FDA perspective.
    Schultheis LW; Mathis LL; Roca RA; Simone AF; Hertz SH; Rappaport BA
    Anesth Analg; 2006 Jul; 103(1):49-51. PubMed ID: 16790624
    [No Abstract]   [Full Text] [Related]  

  • 35. Accelerated approval regulations may need overhaul, panel suggests.
    Finkelstein JB
    J Natl Cancer Inst; 2005 Dec; 97(24):1802-4. PubMed ID: 16368938
    [No Abstract]   [Full Text] [Related]  

  • 36. The FDA Breakthrough-Drug Designation - Four Years of Experience.
    Darrow JJ; Avorn J; Kesselheim AS
    N Engl J Med; 2018 Apr; 378(15):1444-1453. PubMed ID: 29641970
    [No Abstract]   [Full Text] [Related]  

  • 37. Access to unapproved drugs.
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):2-4. PubMed ID: 20345193
    [No Abstract]   [Full Text] [Related]  

  • 38. Individual patient treatment use of unapproved drugs: a new option for the seriously ill.
    Simon LS; Green A
    J Pain Palliat Care Pharmacother; 2010 Mar; 24(1):19-22. PubMed ID: 20345195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical trial registry--update.
    Novack GD
    Ocul Surf; 2009 Oct; 7(4):212-4. PubMed ID: 19948104
    [No Abstract]   [Full Text] [Related]  

  • 40. The regulation of investigational drugs.
    Kessler DA
    N Engl J Med; 1989 Feb; 320(5):281-8. PubMed ID: 2643051
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.